v3.25.4
Schedule I (Tables)
 12 Months Ended
Dec. 31, 2025
Condensed Financial Statements, Captions [Line Items]  
Schedule of Maturities of Long-term Debt [Table Text Block]
Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:
(in millions)
2026$6,082 
20273,530 
20283,605 
20293,655 
20303,855 
Thereafter58,657 
Parent Company [Member]  
Condensed Financial Statements, Captions [Line Items]  
Condensed Balance Sheet [Table Text Block]
Condensed Financial Information of Registrant
(Parent Company Only)
UnitedHealth Group
Condensed Balance Sheets
 
(in millions, except per share data)December 31,
2025		December 31,
2024
Assets  
Current assets:  
Cash and cash equivalents$303 $234 
Other current assets1,533 411 
Total current assets1,836 645 
Equity in net assets of subsidiaries206,415 179,888 
Long-term notes receivable from subsidiaries679 6,062 
Other assets673 920 
Total assets$209,603 $187,515 
Liabilities and shareholders’ equity
Current liabilities:
Accounts payable and accrued liabilities
$2,812 $1,501 
Intercompany payable, net 10,236 679 
Short-term notes payable to subsidiaries2,503 2,016 
Short-term borrowings and current maturities of long-term debt5,887 4,348 
Total current liabilities21,438 8,544 
Long-term debt, less current maturities71,794 71,831 
Long-term notes payable to subsidiaries21,676 14,405 
Other liabilities585 77 
Total liabilities115,493 94,857 
Commitments and contingencies (Note 4)
Shareholders’ equity:
Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding
— — 
Common stock, $0.01 par value - 3,000 shares authorized; 906 and 915 issued and outstanding
9 9 
Additional paid-in capital559 — 
Retained earnings95,603 96,036 
Accumulated other comprehensive loss(2,061)(3,387)
Total UnitedHealth Group shareholders’ equity94,110 92,658 
Total liabilities and shareholders’ equity$209,603 $187,515 
Condensed Statement of Comprehensive Income [Table Text Block]
Condensed Financial Information of Registrant
(Parent Company Only)
UnitedHealth Group
Condensed Statements of Comprehensive Income
 
 For the Years Ended December 31,
(in millions)202520242023
Revenues: 
Investment and other income$154 $368 $312 
Total revenues154 368 312 
Operating costs:
Operating costs
10 108 35 
Interest expense
4,780 4,544 3,469 
Total operating costs4,790 4,652 3,504 
Loss before income taxes(4,636)(4,284)(3,192)
Benefit for income taxes974 1,032 654 
Loss of parent company(3,662)(3,252)(2,538)
Equity in undistributed income of subsidiaries15,718 17,657 24,919 
Net earnings12,056 14,405 22,381 
Other comprehensive income1,326 3,640 1,366 
Comprehensive income$13,382 $18,045 $23,747 
Condensed Cash Flow Statement [Table Text Block]
Condensed Financial Information of Registrant
(Parent Company Only)
UnitedHealth Group
Condensed Statements of Cash Flows
 
 For the Years Ended December 31,
(in millions)202520242023
Operating activities 
Cash flows from operating activities$13,311 $4,852 $17,443 
Investing activities
Issuances of notes to subsidiaries(3,901)(349)(41)
Repayments of notes to subsidiaries8,655 225 817 
Cash paid for acquisitions and other transactions(4,648)(13,750)(8,144)
Return of capital to parent company901 21 639 
Capital contributions to subsidiaries(6,822)— (2,472)
Cash received from dispositions, net458 2,444 624 
Other, net— 30 286 
Cash flows used for investing activities(5,357)(11,379)(8,291)
Financing activities
Common stock repurchases(5,545)(9,000)(8,000)
Proceeds from common stock issuances827 1,846 1,353 
Cash dividends paid(7,916)(7,533)(6,761)
Proceeds from (repayments of) short-term borrowings, net807 (151)11 
Proceeds from issuance of long-term debt2,969 17,811 6,394 
Repayments of long-term debt(3,050)(3,000)(2,125)
(Repayments of) proceeds from short-term notes from subsidiaries, net(677)(7,966)1,188 
Proceeds from long-term notes from subsidiaries7,162 14,396 — 
Repayments of long-term notes from subsidiaries(2,120)(28)— 
Other, net(342)(390)(702)
Cash flows (used for) from financing activities(7,885)5,985 (8,642)
Increase (decrease) in cash and cash equivalents69 (542)510 
Cash and cash equivalents, beginning of period234 776 266 
Cash and cash equivalents, end of period$303 $234 $776 
Supplemental cash flow disclosures
Cash paid for interest$4,817 $4,241 $3,257 
Cash paid for income taxes1,119 2,450 4,426 
Schedule of Maturities of Long-term Debt [Table Text Block]
Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:
(in millions)
2026$5,900 
20273,425 
20283,500 
20293,550 
20303,750 
Thereafter58,552